Answers are grounded in this paper and cite their sources.
OBJECTIVE Among patients undergoing surgery for cervical spondylotic myelopathy (CSM), the prevalence of gait disturbance and the likelihood of gait improvement remain unclear. The aim of this study was to determine the prevalence and prognosis of gait disturbance in CSM and identify factors associated with gait improvement postoperatively. METHODS This was a retrospective analysis of the CSM cohort of the prospectively collected 14-site Spine CORe™ Study Group Quality Outcomes Database (QOD) registry. Outcomes of interest included postoperative ambulatory function at 24 months defined by lower extremity score on the modified Japanese Orthopaedic Association scale and predictors of improved ambulation. The p values for descriptive statistics were obtained using paired and unpaired t-tests and chi-square tests as appropriate. For multivariable analysis, a logistic regression model was fit for improvement in gait in the subset of patients with baseline gait impairment. RESULTS Of the 1141 patients meeting prespecified inclusion criteria, 1135 had baseline gait data; of these, 877 (77.3%) had baseline gait dysfunction and 258 (22.7%) did not. At baseline, patients with gait dysfunction were older (61.5 ± 11.6 vs 57.2 ± 11.7 years, p < 0.001), had higher BMI (30.4 ± 6.6 vs 29.3 ± 6.0 kg/m 2 , p = 0.008), were less likely to have private insurance (46.0% vs 67.4%, p < 0.001), and had more comorbidities. Preoperatively, patients with gait dysfunction had worse neck disability (Neck Disability Index [NDI], 41.0 ± 20.8 vs 30.2 ± 18.4, p < 0.001) and quality of life (EQ-VAS, 56.2 ± 21.4 vs 70.0 ± 18.9, p < 0.001; and EQ-5D, 0.5 ± 0.2 vs 0.7 ± 0.2, p < 0.001). Patients with impaired ambulation at baseline were less satisfied with surgery at 24 months (North American Spine Society satisfaction questionnaire [NASS] score 1, 51.4% vs 60.9%, p = 0.004). Among 596 patients with gait dysfunction who received follow-up postoperatively at 24 months, 304 (51.0%) showed improvement and 292 (49.0%) did not. Patients who improved also demonstrated greater improvement in visual analog scale (VAS) neck pain (−3.3 ± 3.2 vs −2.1 ± 3.9, p < 0.001) and arm pain (−3.2 ± 3.9 vs −2.1 ± 3.9, p < 0.001) scores, as well as better NDI (16.5 ± 17.4 vs 26.8 ± 20.9, p < 0.001), EQ-VAS (74.1 ± 20.0 vs 60.2 ± 23.2, p < 0.001), EQ-5D (0.8 ± 0.2 vs 0.6 ± 0.2, p < 0.001), and NASS (score 1, 74.0% vs 53.8%, p < 0.001) scores. Multivariable analyses revealed that lower BMI (OR 1.01, 95% CI 1.00–1.02, p = 0.01) and lower American Society of Anesthesiologists (ASA) class (for ASA class I or II, OR 1.7, 95% CI 1.04–2.80, p = 0.04) were associated with gait improvement. CONCLUSIONS In this cohort, 77.3% of patients who underwent surgery for CSM demonstrated gait dysfunction preoperatively. Of these patients, 51% had gait improvement after cervical spine surgery. Lower BMI and ASA class were associated with improved gait postoperatively. Patients who improved reported superior quality of life, satisfaction with surgery, and decreased pain and disability.
No takes yet. Share an insight, caveat, or question.
Park et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: